DiviDrip · WDNA

WDNA — WisdomTree BioRevolution Fund

WDNA is WisdomTree's WisdomTree BioRevolution Fund (Healthcare). Trading at $17.56. Current dividend yield: 4.33%.

Dividend snapshot

Annual dividend rate$0.82
Current yield4.33%
Payment frequencyAnnually
Next ex-dividend dateDec 25, 2026
Most recent payment dateDec 30, 2025
Last payment amount$0.7705
5-year dividend CAGR
3-year dividend CAGR128.06%
Expense ratio0.45%
Payout ratio0%
Market cap$2M
ExchangeBTS

Recent dividend payments

DateAmount / share
2025-12-26$0.7710
2024-12-26$0.1070

About WDNA

The fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the index whose risk, return and other characteristics resemble the risk, return and other characteristics of the index as a whole. The index is designed to provide exposure to equity securities of exchange listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. The fund is non-diversified.

Track WDNA in DiviDrip

Add WDNA to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-24. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent